Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details)

 v2.3.0.11
Fair Value of Financial Instruments (Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) (USD $)
In Millions
Jun. 30, 2011
Dec. 31, 2010
Assets:    
Cash equivalents $ 130.0 $ 1,307.2
Derivative assets 93.9 45.6
U.S. marketable securities 15.1 22.0
International marketable securities 41.8 63.9
Foreign exchange contracts 30.4 39.0
Total 311.2 1,477.7
Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) [Member]
   
Assets:    
Cash equivalents 130.0 1,307.2
Derivative assets    
U.S. marketable securities 15.1 22.0
International marketable securities 41.8 63.9
Foreign exchange contracts    
Total 186.9 1,393.1
Significant Other Observable Inputs (Level 2) [Member]
   
Assets:    
Cash equivalents    
Derivative assets 29.9 [1]  
U.S. marketable securities    
International marketable securities    
Foreign exchange contracts 30.4 39.0
Total 60.3 39.0
Significant Unobservable Input (Level 3) [Member]
   
Assets:    
Cash equivalents    
Derivative assets 64.0 45.6
U.S. marketable securities    
International marketable securities    
Foreign exchange contracts    
Total $ 64.0 $ 45.6
[1] Derivative assets includes $14.1 million classified as Accounts receivable on the Statement of Unaudited Condensed Consolidated Financial Position as of June 30, 2011. Refer to NOTE 3 - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES for further information.